Innoviva, Inc.
INVA· Nasdaq
INVAInnoviva, Inc.
Filed Feb 25, 2021 · 10-K · 56 days after period end · 0001104659-21-028328
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $90.48M | $75.97M | $79.86M | $69.52M |
| Net Income | $75.02M | $57.86M | $269.22M | $58.51M |
| EPS Diluted | — | $0.42 | $2.34 | $0.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Innoviva, Inc. · CIK 1080014 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 25, 2021 · 56 d after period end
